Clinical Trials
1
Active:0
Completed:1
Trial Phases
1 Phases
Phase 2:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 2
1 (100.0%)Safety and Immunogenicity Study of Tdap Vaccinations for Plasma Donors
Phase 2
Completed
- Conditions
- Tetanus, Diphtheria and Acellular Pertussis Vaccination
- Interventions
- Biological: Tdap
- First Posted Date
- 2022-12-23
- Last Posted Date
- 2025-06-27
- Lead Sponsor
- ABO Holdings, Inc.
- Target Recruit Count
- 100
- Registration Number
- NCT05662852
- Locations
- 🇺🇸
ABO Plasma, Glassboro, New Jersey, United States
News
No news found